JP2024512472A5 - - Google Patents
Info
- Publication number
- JP2024512472A5 JP2024512472A5 JP2023556979A JP2023556979A JP2024512472A5 JP 2024512472 A5 JP2024512472 A5 JP 2024512472A5 JP 2023556979 A JP2023556979 A JP 2023556979A JP 2023556979 A JP2023556979 A JP 2023556979A JP 2024512472 A5 JP2024512472 A5 JP 2024512472A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- ethyl
- group
- alkyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21163292.2A EP4059497A1 (en) | 2021-03-17 | 2021-03-17 | C5ar1 inhibitors for treating hypersensitivity reactions to taxanes |
| EP21163292.2 | 2021-03-17 | ||
| EP21217382 | 2021-12-23 | ||
| EP21217382.7 | 2021-12-23 | ||
| PCT/EP2022/057007 WO2022195017A1 (en) | 2021-03-17 | 2022-03-17 | C5ar1 inhibitors for treating hypersensitivity reactions to taxanes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512472A JP2024512472A (ja) | 2024-03-19 |
| JP2024512472A5 true JP2024512472A5 (enExample) | 2025-03-25 |
Family
ID=81307212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023556979A Pending JP2024512472A (ja) | 2021-03-17 | 2022-03-17 | タキサンに対する過敏性反応を治療するためのｃ５ａｒ１阻害薬 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240180888A1 (enExample) |
| EP (1) | EP4308114B1 (enExample) |
| JP (1) | JP2024512472A (enExample) |
| BR (1) | BR112023018826A2 (enExample) |
| CA (1) | CA3212816A1 (enExample) |
| DK (1) | DK4308114T3 (enExample) |
| FI (1) | FI4308114T3 (enExample) |
| HR (1) | HRP20260351T1 (enExample) |
| IL (1) | IL305727A (enExample) |
| LT (1) | LT4308114T (enExample) |
| PL (1) | PL4308114T3 (enExample) |
| RS (1) | RS67911B1 (enExample) |
| SM (1) | SMT202600118T1 (enExample) |
| WO (1) | WO2022195017A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202543631A (zh) * | 2024-03-14 | 2025-11-16 | 美商凡況生化公司 | 嗒嗪酮ｃ５ａｒ１拮抗劑及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998053811A1 (en) * | 1997-05-27 | 1998-12-03 | Baker Norton Pharmaceuticals, Inc. | Method and compositions for administering taxanes orally to human patients |
| WO1999022759A1 (en) * | 1997-10-31 | 1999-05-14 | Walter Reed Army Institute Of Research | Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
| MXPA02004164A (es) * | 1999-10-27 | 2002-10-17 | Baker Norton Pharma | Metodo y composiciones para administrar taxanos por via oral a pacientes humanos. |
| RS55192B1 (sr) | 2005-11-24 | 2017-01-31 | Dompé Farm S P A | Derivati (r)-arilkilamina i farmaceutske kompozicije koje ih sadrže |
| EP3498269A1 (en) * | 2017-12-12 | 2019-06-19 | Dompé farmaceutici S.p.A. | C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain |
-
2022
- 2022-03-17 BR BR112023018826A patent/BR112023018826A2/pt unknown
- 2022-03-17 PL PL22716203.9T patent/PL4308114T3/pl unknown
- 2022-03-17 LT LTEPPCT/EP2022/057007T patent/LT4308114T/lt unknown
- 2022-03-17 WO PCT/EP2022/057007 patent/WO2022195017A1/en not_active Ceased
- 2022-03-17 EP EP22716203.9A patent/EP4308114B1/en active Active
- 2022-03-17 DK DK22716203.9T patent/DK4308114T3/da active
- 2022-03-17 CA CA3212816A patent/CA3212816A1/en active Pending
- 2022-03-17 IL IL305727A patent/IL305727A/en unknown
- 2022-03-17 HR HRP20260351TT patent/HRP20260351T1/hr unknown
- 2022-03-17 SM SM20260118T patent/SMT202600118T1/it unknown
- 2022-03-17 US US18/282,357 patent/US20240180888A1/en active Pending
- 2022-03-17 FI FIEP22716203.9T patent/FI4308114T3/fi active
- 2022-03-17 RS RS20260336A patent/RS67911B1/sr unknown
- 2022-03-17 JP JP2023556979A patent/JP2024512472A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6038213B2 (ja) | 虚脱性糸球体症および他の糸球体疾患の処置のためのグルコシルセラミドシンターゼ阻害 | |
| EP2255848A2 (en) | Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer | |
| TWI511728B (zh) | 包含非典型抗精神病藥物及taar1激動劑之醫藥組合 | |
| RU2492167C2 (ru) | Производные аминотриазола в качестве агонистов alх | |
| EP2550965B1 (en) | Ceramide derivatives for treating polycystic kidney disease | |
| JP2014502979A5 (enExample) | ||
| JP2004512279A (ja) | Ｃｂ１受容体アンタゴニストおよびシブトラミンの組み合わせ、それらからなる医薬組成物、および肥満の治療におけるそれらの使用 | |
| JP2018087232A (ja) | ２−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤 | |
| RU2005121897A (ru) | Производные аминоиндазолов и их применение в качестве ингибиторов киназ | |
| RU98119885A (ru) | Фармацевтическая композиция, содержащая соединение, имеющее ангиотензин ii антагонистическую активность | |
| RU2011153772A (ru) | Фторированные аминотриазольные производные | |
| JP2008502614A5 (enExample) | ||
| RU2006123418A (ru) | Новые антагонисты м3 мускаринового ацетилхолинового рецептора | |
| RU2009108275A (ru) | Соединение сульфонамида или его соль | |
| JP2005504093A5 (enExample) | ||
| JP2020524660A5 (enExample) | ||
| FI4308114T3 (fi) | C5ar1-estäjiä taksaanien aiheuttamien yliherkkyysrektioiden hoitoon | |
| JP2021505647A5 (enExample) | ||
| RU2023126446A (ru) | Предотвращение и лечение реакций гиперчувствительности к таксанам | |
| WO2018197583A1 (en) | Use of a combinational therapy of lsd1 inhibitors with p21 activators in the treatment of cancer | |
| JP2005531547A5 (enExample) | ||
| JP2022044216A (ja) | 新型コロナウイルス感染症（ｃｏｖｉｄ－１９）の予防または治療剤および医薬組成物 | |
| RU2022100101A (ru) | Способы, композиции и наборы комбинированной терапии | |
| JP2026501413A (ja) | 眼粘膜類天疱瘡および／または口腔粘膜類天疱瘡の処置において使用するためのＣ５ａＲ１阻害剤 | |
| JP2017502929A5 (enExample) |